文献速递儿童心血管与肾脏新生儿儿童内分泌与遗传代谢

美国13三体和18三体住院患儿心脏外科治疗的当代趋势

Contemporary Trends in Cardiac Surgical Care for Trisomy 13 and 18 Patients Admitted to Hospitals in the United States.
PubMed 文献 · J Pediatr · 2024-02-08

T13合并先天性心脏病(CHD)占62%(1625/2610),T18合并CHD占73%(3288/4503);接受心脏手术者T13合并CHD为12%,T18合并CHD为17%,所有心脏诊断中接受手术者不足50%。手术队列住院死亡率均低于10%。

要点

  • T13合并CHD占62%(1625/2610),T18合并CHD占73%(3288/4503)。
  • T13合并CHD手术率12%,T18合并CHD手术率17%,所有心脏诊断手术率<50%。
  • 手术队列住院死亡率均<10%,提示存在质量改进空间。

核心结论

  • T13或T18合并CHD患儿接受手术姑息治疗,但全国范围内 prevalence 较低(≤17%)。
  • 鉴于手术死亡率<10%,这些脆弱患儿群体的心脏手术实施可能存在质量改进机会。

研究设计与样本

  • 回顾性研究,使用美国儿科健康信息系统(PHIS)数据。
  • 使用国际疾病分类(ICD)代码识别CHD、心外合并症/畸形及心脏手术实施情况。

主要发现

  • T13合并CHD占62%(1625/2610),T18合并CHD占73%(3288/4503)。
  • 最常见CHD形态为孤立性房间隔/室间隔缺损(T13 40%,T18 42%)及主动脉发育不良/缩窄(T13 21%,T18 23%)。
  • 单心室形态占T13合并CHD的6%(100/1625),占T18合并CHD的5%(167/3288)。
  • T13合并CHD手术率12%,T18合并CHD手术率17%;所有心脏诊断中接受手术者<50%。
  • 非手术患者更可能早产(T13和T18均P<.05);T13手术与非手术患者心外合并症数量相似(中位数2 vs 2,P=.215),T18手术患者多于非手术患者(中位数3 vs 2,P<.001)。

关键数值与推荐

  • T13合并CHD:62%(1625/2610);T18合并CHD:73%(3288/4503)。
  • 孤立性房间隔/室间隔缺损:T13 40%,T18 42%;主动脉发育不良/缩窄:T13 21%,T18 23%。
  • 单心室形态:T13 6%(100/1625),T18 5%(167/3288)。
  • 心脏手术率:T13合并CHD 12%,T18合并CHD 17%;所有心脏诊断<50%。
  • 早产比较P<.05(T13和T18);T13心外合并症中位数2 vs 2(P=.215);T18中位数3 vs 2(P<.001);手术队列住院死亡率<10%。

临床怎么用

  • 临床团队可参考全国手术率(T13合并CHD 12%、T18合并CHD 17%)评估本地实践差异。
  • 对于T13或T18合并CHD患儿,早产与未接受手术相关,决策时需综合评估。
  • 手术队列住院死亡率<10%,提示在 selected 患儿中手术姑息治疗可行。

局限性

  • 回顾性研究设计,使用行政数据库ICD代码识别CHD、合并症和手术,可能存在编码偏倚。
  • 原文未报告手术选择的具体指征、长期生存或术后并发症数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess rates of cardiac surgery and the clinical and demographic features that influence surgical vs nonsurgical treatment of congenital heart disease (CHD) in patients with trisomy 13 (T13) and trisomy 18 (T18) in the United States. STUDY DESIGN: A retrospective study was performed using the Pediatric Health Information System. All hospital admissions of children (<18 years of age) with T13 and T18 in the United States were identified from 2003 through 2022. International Classifications of Disease (ICD) codes were used to identify presence of CHD, extracardiac comorbidities/malformations, and performance of cardiac surgery. RESULTS: Seven thousand one hundred thirteen patients were identified. CHD was present in 62% (1625/2610) of patients with T13 and 73% (3288/4503) of patients with T18. The most common CHD morphologies were isolated atrial/ventricular septal defects (T13 40%, T18 42%) and aortic hypoplasia/coarctation (T13 21%, T18 23%). Single-ventricle morphologies comprised 6% (100/1625) of the T13 and 5% (167/3288) of the T18 CHD cohorts. Surgery was performed in 12% of patients with T13 plus CHD and 17% of patients with T18 plus CHD. For all cardiac diagnoses, <50% of patients received surgery. Nonsurgical patients were more likely to be born prematurely (P < .05 for T13 and T18). The number of extracardiac comorbidities was similar between surgical/nonsurgical patients with T13 (median 2 vs 2, P = .215) and greater in surgical vs nonsurgical patients with T18 (median 3 vs 2, P < .001). Hospital mortality was <10% for both surgical cohorts. CONCLUSIONS: Patients with T13 or T18 and CHD receive surgical palliation, but at a low prevalence (≤17%) nationally. Given operative mortality <10%, opportunity exists perhaps for quality improvement in the performance of cardiac surgery for these vulnerable patient populations.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Greenberg JW, Kulshrestha K, Ramineni A, et al. Contemporary Trends in Cardiac Surgical Care for Trisomy 13 and 18 Patients Admitted to Hospitals in the United States. J Pediatr. 2024. PMID: 38340889. doi:10.1016/j.jpeds.2024.113955

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。